| scholarly article | Q13442814 |
| P50 | author | Victor H Engelhard | Q56930239 |
| P2093 | author name string | J David Peske | |
| Amber B Woods | |||
| P2860 | cites work | Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta | Q21999071 |
| Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3) | Q22009509 | ||
| CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells | Q22010907 | ||
| Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma | Q24629841 | ||
| Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer | Q24633070 | ||
| Targeting selectins and selectin ligands in inflammation and cancer | Q24658204 | ||
| Requirement of the chemokine receptor CXCR3 for acute allograft rejection | Q24676298 | ||
| Characteristics of tertiary lymphoid structures in primary cancers | Q27012852 | ||
| Inflammatory networks and immune surveillance of pancreatic carcinoma | Q27013983 | ||
| The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures | Q27015137 | ||
| Combining radiotherapy and cancer immunotherapy: a paradigm shift | Q27021428 | ||
| Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow | Q27027232 | ||
| The blockade of immune checkpoints in cancer immunotherapy | Q27860852 | ||
| PD-1 and its ligands in tolerance and immunity | Q28131650 | ||
| Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion | Q28131654 | ||
| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
| Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106) | Q47725276 | ||
| Melanoma-intrinsic β-catenin signaling prevents T cell infiltration and anti-tumor immunity | Q50280766 | ||
| Synchrony of high endothelial venules and lymphatic vessels revealed by immunization | Q50476530 | ||
| Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. | Q50754378 | ||
| Ectopic lymphoid structures in primary cutaneous melanoma | Q50850999 | ||
| High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer | Q50859541 | ||
| Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy | Q50954469 | ||
| CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer | Q50955882 | ||
| Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer | Q50993488 | ||
| Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. | Q50996147 | ||
| CD43 functions as a ligand for E-Selectin on activated T cells | Q51811730 | ||
| In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer | Q51889493 | ||
| Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on Western blots | Q52012675 | ||
| C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. | Q52022548 | ||
| Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer | Q52907227 | ||
| Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer | Q53471678 | ||
| IFN-gamma regulates donor CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor | Q53604220 | ||
| Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins | Q54296088 | ||
| Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β. | Q55463248 | ||
| An immune-active tumor microenvironment favors clinical response to ipilimumab | Q56898024 | ||
| Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer | Q56903097 | ||
| Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer | Q56932855 | ||
| Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer | Q56965679 | ||
| Kinetic and mechanical basis of rolling through an integrin and novel Ca2+-dependent rolling and Mg2+-dependent firm adhesion modalities for the alpha 4 beta 7-MAdCAM-1 interaction | Q28204891 | ||
| CCL27-CCR10 interactions regulate T cell-mediated skin inflammation | Q28217086 | ||
| PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells | Q28243975 | ||
| Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated | Q28245528 | ||
| Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells | Q28248489 | ||
| Adoptive immunotherapy for cancer: harnessing the T cell response | Q28262548 | ||
| DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 | Q28285583 | ||
| Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells | Q28287701 | ||
| Coordinated regulation of myeloid cells by tumours | Q28395157 | ||
| Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin | Q28507630 | ||
| Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation | Q28585797 | ||
| Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice | Q28587099 | ||
| Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice | Q28587819 | ||
| Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells | Q28732041 | ||
| T-Cell Function and Migration — Two Sides of the Same Coin | Q29041098 | ||
| Getting to the site of inflammation: the leukocyte adhesion cascade updated | Q29547271 | ||
| Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy | Q29614312 | ||
| Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients | Q29617771 | ||
| Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity | Q29617967 | ||
| IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity | Q29620119 | ||
| Natural Innate and Adaptive Immunity to Cancer | Q29620313 | ||
| Immunologic correlates of the abscopal effect in a patient with melanoma | Q29620334 | ||
| Genetic basis for clinical response to CTLA-4 blockade in melanoma | Q29620594 | ||
| The immune contexture in human tumours: impact on clinical outcome | Q29620667 | ||
| PD-1 blockade induces responses by inhibiting adaptive immune resistance | Q29620856 | ||
| Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules | Q30047232 | ||
| Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity | Q30299955 | ||
| Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control | Q30311891 | ||
| Peripheral tissue homing receptors enable T cell entry into lymph nodes and affect the anatomical distribution of memory cells | Q30411038 | ||
| Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment | Q30415355 | ||
| Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer | Q30419813 | ||
| Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma | Q30422102 | ||
| Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma | Q30423599 | ||
| CD8 T cells activated in distinct lymphoid organs differentially express adhesion proteins and coexpress multiple chemokine receptors | Q30432672 | ||
| Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice | Q30433217 | ||
| Tumor masses support naive T cell infiltration, activation, and differentiation into effectors | Q30433292 | ||
| The significance of lymphocytic infiltration in neuroblastoma | Q36039464 | ||
| Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype | Q36059631 | ||
| Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes | Q36219735 | ||
| Regulation of lymph node vascular growth by dendritic cells. | Q36228770 | ||
| In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor | Q36229738 | ||
| The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1 | Q36230719 | ||
| The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. | Q36235481 | ||
| The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cells. | Q36236881 | ||
| The lymphocyte homing receptors: gatekeepers of the multistep paradigm | Q36282864 | ||
| A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer | Q36299662 | ||
| PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines | Q36334073 | ||
| Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma | Q36361169 | ||
| Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma | Q36368808 | ||
| High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes | Q36373347 | ||
| Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma | Q36375683 | ||
| Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy | Q36378276 | ||
| Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells | Q36399686 | ||
| Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues | Q36402630 | ||
| Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors | Q36402716 | ||
| Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death | Q36403093 | ||
| Lymphoid neogenesis in chronic inflammatory diseases. | Q36405080 | ||
| Lymphoid organ development: from ontogeny to neogenesis | Q36426808 | ||
| T-cell homing specificity and plasticity: new concepts and future challenges | Q36437343 | ||
| Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. | Q36456711 | ||
| Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice | Q36497106 | ||
| Radiation-guided P-selectin antibody targeted to lung cancer | Q36537700 | ||
| Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer | Q36663615 | ||
| Vascular E-selectin expression correlates with CD8 lymphocyte infiltration and improved outcome in Merkel cell carcinoma | Q36816430 | ||
| Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma | Q36853440 | ||
| Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells | Q36916400 | ||
| Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo | Q36946528 | ||
| Lymphoid tissue engineering: invoking lymphoid tissue neogenesis in immunotherapy and models of immunity | Q37012768 | ||
| Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia | Q37040899 | ||
| Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin | Q56965716 | ||
| Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures | Q56965922 | ||
| Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells | Q58234949 | ||
| Relative roles of ICAM-1 and VCAM-1 in the pathogenesis of experimental radiation-induced intestinal inflammation | Q58326763 | ||
| P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues | Q58808007 | ||
| Vascular normalization in Rgs5-deficient tumours promotes immune destruction | Q58897988 | ||
| Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis | Q59276609 | ||
| Functional Characterization of the CCL25 Promoter in Small Intestinal Epithelial Cells Suggests a Regulatory Role for Caudal-Related Homeobox (Cdx) Transcription Factors | Q60042100 | ||
| A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with beta 7 integrins and memory differentiation | Q60673550 | ||
| The α(1,3)Fucosyltransferase Fuc-TVII Controls Leukocyte Trafficking through an Essential Role in L-, E-, and P-selectin Ligand Biosynthesis | Q60719538 | ||
| Reversal of in vitro T cell clonal anergy by IL-2 stimulation | Q68181442 | ||
| Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma | Q69484555 | ||
| In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma | Q69789630 | ||
| E-selectin gene induction by ionizing radiation is independent of cytokine induction | Q70882024 | ||
| Differential expression of an E-selectin ligand (SLex) by two Chinese hamster ovary cell lines transfected with the same alpha (1,3)-fucosyltransferase gene (ELFT) | Q71606780 | ||
| Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2 | Q72275233 | ||
| Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response | Q72359898 | ||
| Divergent inducible expression of P-selectin and E-selectin in mice and primates | Q73205667 | ||
| Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells | Q73271114 | ||
| B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion | Q73343324 | ||
| Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression | Q73344300 | ||
| Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression | Q73370050 | ||
| Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue | Q73588426 | ||
| Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma | Q74477264 | ||
| The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection | Q74530058 | ||
| Priming of naive T cells inside tumors leads to eradication of established tumors | Q75221014 | ||
| CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity | Q79712657 | ||
| CD43 collaborates with P-selectin glycoprotein ligand-1 to mediate E-selectin-dependent T cell migration into inflamed skin | Q79718058 | ||
| T-cell distribution and adhesion receptor expression in metastatic melanoma | Q80249359 | ||
| Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication | Q80491604 | ||
| Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue | Q80554111 | ||
| Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments | Q81456293 | ||
| Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer | Q83761844 | ||
| Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy | Q84776409 | ||
| Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses | Q84958034 | ||
| High endothelial venule-like vessels and lymphocyte recruitment in testicular seminoma | Q87277368 | ||
| CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease | Q30435000 | ||
| Microbubbles in ultrasound-triggered drug and gene delivery | Q30438994 | ||
| Activated CD8 T cells redistribute to antigen-free lymph nodes and exhibit effector and memory characteristics. | Q30439065 | ||
| Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells. | Q30442645 | ||
| Rapid Acquisition of Tissue-specific Homing Phenotypes by CD4+ T Cells Activated in Cutaneous or Mucosal Lymphoid Tissues | Q33183256 | ||
| Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. | Q33188469 | ||
| ELFT: a gene that directs the expression of an ELAM-1 ligand | Q33259321 | ||
| Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice | Q33399367 | ||
| MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis | Q33744153 | ||
| Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation | Q33848077 | ||
| Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors | Q33862822 | ||
| Interleukin-2 in the treatment of renal cancer | Q33893642 | ||
| Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades | Q33989863 | ||
| Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer | Q34031748 | ||
| Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice | Q34110300 | ||
| The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapy | Q34111824 | ||
| Lack of functional selectin ligand interactions compromises long term tumor protection by CD8+ T cells | Q34168631 | ||
| gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma | Q34188859 | ||
| The development of inducible bronchus-associated lymphoid tissue depends on IL-17. | Q34191942 | ||
| Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer | Q34210036 | ||
| Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells | Q34211233 | ||
| Immune surveillance in the skin: mechanisms and clinical consequences | Q34308222 | ||
| Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells | Q34444540 | ||
| Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-γ in experimental dry eye. | Q34476263 | ||
| Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. | Q34568588 | ||
| Model predicting survival in stage I melanoma based on tumor progression | Q34669608 | ||
| Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine | Q34677842 | ||
| Th17 cells in cancer: help or hindrance? | Q34913808 | ||
| The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. | Q35009076 | ||
| Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. | Q35013206 | ||
| CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice | Q35015717 | ||
| Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer | Q35061159 | ||
| Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array Profiling | Q35070183 | ||
| Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants | Q35151318 | ||
| B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice | Q37069120 | ||
| Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumours | Q37096002 | ||
| An alpha4beta1 integrin antagonist decreases airway inflammation in ovalbumin-exposed mice | Q37105629 | ||
| Autocrine CCL3 and CCL4 Induced by the Oncoprotein LMP1 Promote Epstein-Barr Virus-Triggered B Cell Proliferation | Q37123246 | ||
| Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies | Q37125759 | ||
| Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice | Q37207114 | ||
| CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice | Q37299504 | ||
| A developmental switch in lymphocyte homing receptor and endothelial vascular addressin expression regulates lymphocyte homing and permits CD4+ CD3- cells to colonize lymph nodes | Q37307203 | ||
| The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer. | Q37308863 | ||
| In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes. Results of a double gene marking trial | Q37350605 | ||
| STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. | Q37502349 | ||
| Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer. | Q37507341 | ||
| Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies. | Q37599478 | ||
| Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity | Q37734258 | ||
| Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy | Q37778702 | ||
| New insights into the development of lymphoid tissues | Q37779724 | ||
| Immune parameters affecting the efficacy of chemotherapeutic regimens | Q37848665 | ||
| Tumor angiogenesis: molecular pathways and therapeutic targets | Q37953773 | ||
| HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes | Q38047190 | ||
| From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer | Q38098366 | ||
| The integration of T cell migration, differentiation and function | Q38100061 | ||
| Th17 cells in cancer: the ultimate identity crisis. | Q38225542 | ||
| Tertiary lymphoid structures in cancer and beyond | Q38274486 | ||
| Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells | Q38462714 | ||
| Efficient eradication of subcutaneous but not of autochthonous gastric tumors by adoptive T cell transfer in an SV40 T antigen mouse model | Q39678259 | ||
| Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. | Q39722616 | ||
| Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. | Q40031362 | ||
| Differential mechanisms for T lymphocyte recruitment in normal and neoplastic human gastric mucosa | Q40389810 | ||
| Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor | Q40412166 | ||
| ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivo. | Q40450045 | ||
| Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs. | Q40455900 | ||
| The immunization site of cytokine-secreting tumor cell vaccines influences the trafficking of tumor-specific T lymphocytes and antitumor efficacy against regional tumors | Q40495353 | ||
| Coley's toxins, tumor necrosis factor and cancer research: a historical perspective | Q40510386 | ||
| Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. | Q40564039 | ||
| Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells | Q40602668 | ||
| Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster | Q40618158 | ||
| Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity | Q40699722 | ||
| T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion | Q41400520 | ||
| Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. | Q41541656 | ||
| The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells | Q41687602 | ||
| Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo | Q41732041 | ||
| Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen | Q41870799 | ||
| 12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy? | Q41883987 | ||
| Exomics and immunogenics: Bridging mutational load and immune checkpoints efficacy | Q41983246 | ||
| Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice | Q42036256 | ||
| Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response. | Q42186944 | ||
| E-selectin, thymus- and activation-regulated chemokine/CCL17, and intercellular adhesion molecule-1 are constitutively coexpressed in dermal microvessels: a foundation for a cutaneous immunosurveillance system | Q42455866 | ||
| Tumors as elusive targets of T-cell-based active immunotherapy | Q35155955 | ||
| STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. | Q35263440 | ||
| Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma | Q35329190 | ||
| IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells | Q35369944 | ||
| Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer | Q35463514 | ||
| High endothelial venules as traffic control points maintaining lymphocyte population homeostasis in lymph nodes | Q35604059 | ||
| A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma. | Q35617517 | ||
| Targeting T cell responses by selective chemokine receptor expression | Q35682772 | ||
| Ligands for L-selectin: homing, inflammation, and beyond | Q35698423 | ||
| Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. | Q35889643 | ||
| Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients | Q36020800 | ||
| Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma | Q42482085 | ||
| Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function | Q42486404 | ||
| Fibroblast-type reticular stromal cells regulate the lymph node vasculature | Q42808843 | ||
| P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin | Q42947599 | ||
| T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. | Q43561148 | ||
| NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. | Q43562662 | ||
| Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. | Q43785551 | ||
| Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases | Q43874383 | ||
| Transition from rolling to firm adhesion is regulated by the conformation of the I domain of the integrin lymphocyte function-associated antigen-1. | Q44170571 | ||
| The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally | Q44367894 | ||
| Importance of IFN-gamma-mediated expression of endothelial VCAM-1 on recruitment of CD8+ T cells into the brain during chronic infection with Toxoplasma gondii | Q44929042 | ||
| MAdCAM-1 expression and regulation in murine colonic endothelial cells in vitro | Q45285904 | ||
| The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma. | Q45403989 | ||
| Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98 | Q46389190 | ||
| alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow | Q46523925 | ||
| Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. | Q46655434 | ||
| Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy | Q46721130 | ||
| Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes | Q46755323 | ||
| CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction | Q47644730 | ||
| The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues | Q47713235 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 263-307 | |
| P577 | publication date | 2015-06-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Advances in Cancer Research | Q3113522 |
| P1476 | title | Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment | |
| P478 | volume | 128 |
| Q39329596 | Adoptive T cell therapy: An overview of obstacles and opportunities. |
| Q91892155 | Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation |
| Q92970937 | Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment |
| Q38843235 | Challenges in vaccine therapy in hematological malignancies and strategies to overcome them |
| Q58768316 | Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site |
| Q64232953 | Combinatorial therapy of immune checkpoint and cancer pathways provides a novel perspective on ovarian cancer treatment |
| Q55422912 | Comparison of Burnet's clonal selection theory with tumor cell-clone development. |
| Q38757522 | Crosstalk signaling in targeted melanoma therapy |
| Q36791673 | Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities |
| Q45071748 | Differential Expression of Homing Receptor Ligands on Tumor-Associated Vasculature that Control CD8 Effector T-cell Entry. |
| Q62604186 | HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy |
| Q47136084 | Harness the synergy between targeted therapy and immunotherapy: what have we learned and where are we headed? |
| Q40146282 | IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils. |
| Q103826173 | Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients |
| Q89737965 | Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells |
| Q40858015 | Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis |
| Q56369727 | Lymphoid aggregates in desmoplastic melanoma have features of tertiary lymphoid structures |
| Q96304654 | Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment |
| Q50094781 | Migrating into the Tumor: a Roadmap for T Cells |
| Q27313748 | PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model |
| Q55401142 | Polysaccharides from Chinese Herbal Lycium barbarum Induced Systemic and Local Immune Responses in H22 Tumor-Bearing Mice. |
| Q92911827 | Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors |
| Q58773649 | Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment |
| Q57044561 | Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility |
| Q92143443 | Research progress and design optimization of CAR-T therapy for pancreatic ductal adenocarcinoma |
| Q38873974 | T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy. |
| Q97867213 | TGFβ biology in cancer progression and immunotherapy |
| Q104795035 | Targeting TGFβ signal transduction for cancer therapy |
| Q55007801 | The Progress of T Cell Immunity Related to Prognosis in Gastric Cancer. |
| Q39194833 | The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes |
| Q41636554 | VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma |
| Q60938392 | Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer |
| Q92728797 | [New Advances in the Treatment for Small Cell Lung Cancer] |
Search more.